• LAST PRICE
    25.4450
  • TODAY'S CHANGE (%)
    Trending Down-0.8550 (-3.2510%)
  • Bid / Lots
    25.4200/ 1
  • Ask / Lots
    25.4700/ 2
  • Open / Previous Close
    26.5000 / 26.3000
  • Day Range
    Low 25.2500
    High 26.6000
  • 52 Week Range
    Low 23.1400
    High 35.5600
  • Volume
    123,560
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 26.3
TimeVolumeMIRM
09:32 ET775626.5112
09:34 ET40026.39
09:36 ET38426.39
09:39 ET12626.285
09:41 ET20026.44
09:43 ET10026.49
09:45 ET50326.45
09:50 ET80026.31
09:52 ET10026.385
09:54 ET40026.23
09:56 ET115626.05
09:59 ET10025.97
10:01 ET30025.78
10:03 ET135025.91
10:06 ET10025.825
10:08 ET373125.775
10:10 ET60025.655
10:15 ET10025.61
10:17 ET30025.62
10:19 ET10025.66
10:21 ET30025.62
10:24 ET40025.49
10:26 ET60025.5
10:30 ET60025.55
10:32 ET108825.5
10:33 ET153625.59
10:35 ET10025.64
10:37 ET30025.645
10:42 ET30525.615
10:46 ET18825.63
10:48 ET20025.645
10:50 ET50025.66
10:51 ET30825.625
10:53 ET10025.625
11:00 ET60825.59
11:06 ET20025.645
11:08 ET35525.61
11:09 ET111225.62
11:11 ET10025.6
11:13 ET369625.5946
11:15 ET165025.65
11:18 ET50025.685
11:24 ET10025.64
11:27 ET90025.59
11:29 ET40025.46
11:31 ET53025.4057
11:38 ET56125.37
11:40 ET31225.425
11:42 ET96025.39
11:45 ET10025.43
11:47 ET30025.425
11:49 ET38825.43
11:54 ET10025.43
11:56 ET40025.47
11:58 ET10025.475
12:03 ET80025.4
12:05 ET503925.5
12:09 ET10025.5
12:16 ET1576325.625
12:18 ET20025.67
12:20 ET10025.645
12:21 ET10025.62
12:25 ET105025.62
12:30 ET10025.63
12:32 ET100025.59
12:34 ET290025.7
12:36 ET10025.7
12:48 ET75625.58
12:52 ET25025.555
12:57 ET30025.535
01:06 ET40025.535
01:12 ET12625.5476
01:14 ET10025.52
01:15 ET10025.51
01:21 ET12625.47
01:24 ET100025.5
01:26 ET70025.535
01:32 ET10025.52
01:35 ET30025.535
01:37 ET97725.515
01:39 ET10025.49
01:42 ET20025.445
01:53 ET242825.47
02:02 ET253625.3
02:08 ET25025.27
02:09 ET10025.25
02:11 ET19325.25
02:18 ET220025.32
02:20 ET10025.3
02:24 ET70025.4
02:27 ET10025.39
02:29 ET10025.37
02:36 ET52825.445
02:38 ET10025.445
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMIRM
Mirum Pharmaceuticals Inc
1.1B
-6.7x
---
United StatesARCT
Arcturus Therapeutics Holdings Inc
1.0B
-10.8x
---
United StatesMNKD
MannKind Corp
1.3B
199.3x
---
United StatesAUPH
Aurinia Pharmaceuticals Inc
775.2M
-12.5x
---
United StatesXNCR
Xencor Inc
1.5B
-10.1x
---
United StatesDNA
Ginkgo Bioworks Holdings Inc
1.2B
-1.2x
---
As of 2024-06-06

Company Information

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development and commercialization of therapies for debilitating rare and orphan diseases. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. It is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.

Contact Information

Headquarters
950 Tower Ln Ste 1050FOSTER CITY, CA, United States 94404-4251
Phone
650-667-4085
Fax
302-269-3855

Executives

Independent Non-Executive Chairman of the Board
Michael Grey
President, Chief Operating Officer
Peter Radovich
Chief Executive Officer, Co-Founder, Director
Christopher Peetz
Chief Financial Officer
Eric Bjerkholt
Chief Scientific Officer
Pamela Vig

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.1B
Revenue (TTM)
$224.0M
Shares Outstanding
47.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.10
EPS
$-3.82
Book Value
$5.32
P/E Ratio
-6.7x
Price/Sales (TTM)
5.1
Price/Cash Flow (TTM)
---
Operating Margin
-70.34%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.